LIVE MARKET TRACKER :   BSE SENSEX   27459.23      |    NSE NIFTY 8337.00    
GLOBAL MARKETS :  NASDAQ 5089.21   +0.98%    |    FSI London 6555.28   +0.77%    |    NIKKEI Japan 20328.89   -0.10%
  USD GBP EUR CAD AUD INR
USD - 0.6408 0.9041 1.2932 1.3622 63.8390
GBP 1.5614 - 1.4116 2.0189 2.1270 99.6782
EUR 1.1064 0.7090 - 1.4308 1.5066 70.6315
CAD 0.7736 0.4958 0.6994 - 1.0584 49.3881
AUD 0.7346 0.4708 0.6678 0.9502 - 46.8859
INR 0.0157 0.0100 0.0142 0.0203 0.0213 -
Indian-Commodity  :  Equity & Shares  :  Orbit Exports trades in pink of its health on the BSE

Orbit Exports trades in pink of its health on the BSE (07-Dec-2012)

Orbit Exports is currently trading at Rs 63.45, up by 2.60 points or 4.27% from its previous closing of Rs 60.85 on the BSE.

The scrip opened at Rs 62.00 and has touched a high and low of Rs 63.45 and Rs 62.00 respectively. So far 620 shares were traded on the counter.

The BSE group 'T' stock of face value Rs 10 has touched a 52 week high of Rs 69.30 on 15-Feb-2012 and a 52 week low of Rs 41.00 on 30-Jul-2012.

Last one week high and low of the scrip stood at Rs 62.80 and Rs 55.25 respectively. The current market cap of the company is Rs 78.73 crore.

The promoters holding in the company stood at 48.76% while Non-Institutions held 51.24% of the company's stake.

ICRA has reaffirmed 'BBB (stable)' rating assigned to Orbit Exports' Rs 13.36 crore worth Term Loan, Rs 15 crore worth Cash credit and Rs 5.64 crore worth proposed bank facilities. Further, the credit rating agency has upgraded the rating to 'A2+' for company's Rs 12.5 crore and 6 crore fun based limits, respectively.

Orbit Exports, a company registered under the Indian Companies Act, 1956, is a government recognised Star Export House engaged in the manufacture and export of fancy fabrics.


Top News Today
Glenmark Pharma, SAIL and Prestige Estate to see some action
(28-Jul-2015)

Glenmark Pharma, SAIL and Prestige Estate to see some actionThe US court ruled that India's Glenmark Pharmaceuticals' proposed generic version of Bayer AG's Finacea, a gel for treating the common skin condition rosacea, infringes Bayer's patent. The federal court......click on news to read complete article.

No need to fear any “knee-jerk” reaction on the SIT report: Arun Jaitley
(28-Jul-2015)

No need to fear any “knee-jerk” reaction on the SIT report: Arun JaitleyIn its bid to soothe the nerves of panic-stricken investors, Finance Minister Arun Jaitley has said they need not fear any “knee-jerk” reaction from the government on the SIT report, which had recommended......click on news to read complete article.

SIT recommends enacting tough laws to curb black money
(27-Jul-2015)

SIT recommends enacting tough laws to curb black moneyThe Supreme Court-appointed special investigation team (SIT) headed by Justice M B Shah (retd)  has recommended enacting tough laws to curb betting in cricket, bring donations to education and......click on news to read complete article.

International Stock News
US markets extend southward journey for fourth straight session
(25-Jul-2015)

US markets extend southward journey for fourth straight sessionExtending their southward journey for fourth straight session, US Markets ended the Friday's session with a cut of around a percentage point. Sentiments remained downbeat with report from the Commerce......click on news to read complete article.

US markets closed lower for third straight session
(24-Jul-2015)

US markets closed lower for third straight sessionThe US markets closed lower on Thursday, after the selling pressure accelerated in the afternoon session and the main indexes closed with losses for the third straight day, led lower by utilities, materials......click on news to read complete article.

US markets closed lower; Dow suffers triple-digit drop
(22-Jul-2015)

US markets closed lower; Dow suffers triple-digit dropThe US markets closed lower on Tuesday, with Dow posting triple-digit drop after IBM and United Technologies Corporation reported disappointing quarterly reports. IBM is the second highest-weighted component......click on news to read complete article.

 

     
  
Recent Equity & Shares News
 
EquityInvestmentCompany ReportsIPO
Disclaimer
By clicking on this page you accept all the terms and conditions framed by us. News made available here are for informational purpose only. While utmost care has been taken in providing the same. We claim no responsibility for its accuracy. Readers of this blog who make their decision based on the information posted here are solely responsible for their actions.